SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000902664-18-000144
Filing Date
2018-01-11
Accepted
2018-01-11 13:03:07
Documents
1

Document Format Files

Seq Description Document Type Size
1 MARINUS PHARMACEUTICALS, INC. p18-0088sc13ga.htm SC 13G/A 109779
  Complete submission text file 0000902664-18-000144.txt   111310
Mailing Address 170 N RADNOR CHESTER RD SUITE 250 RADNOR PA 19087
Business Address 170 N RADNOR CHESTER RD SUITE 250 RADNOR PA 19087 484-801-4670
MARINUS PHARMACEUTICALS INC (Subject) CIK: 0001267813 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-88269 | Film No.: 18523249
SIC: 2834 Pharmaceutical Preparations

Mailing Address 109 STATE STREET 5TH FLOOR BOSTON MA 02109
Business Address 109 STATE STREET 5TH FLOOR BOSTON MA 02109 617-587-7507
Granite Point Capital Management, L.P. (Filed by) CIK: 0001599562 (see all company filings)

IRS No.: 582680000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A